207 related articles for article (PubMed ID: 27781199)
1. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Iwamoto T; Okabe J; Takamura M; Fujita N; Hori M; Takehara T; Kudo M; Murakami T
Liver Cancer; 2016 Oct; 5(4):269-279. PubMed ID: 27781199
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Hori M; Kudo M; Murakami T
Dig Dis; 2013; 31(5-6):485-9. PubMed ID: 24281025
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
[TBL] [Abstract][Full Text] [Related]
5. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
7. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability.
Minami Y; Minami T; Takita M; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
Hepatol Res; 2020 Jan; 50(1):67-74. PubMed ID: 31301213
[TBL] [Abstract][Full Text] [Related]
10. Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging.
Minami Y; Kudo M
Front Oncol; 2021; 11():593636. PubMed ID: 33747913
[TBL] [Abstract][Full Text] [Related]
11. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
[TBL] [Abstract][Full Text] [Related]
12. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
13. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
[TBL] [Abstract][Full Text] [Related]
15. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
16. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Ohama H; Matsumoto Y; Nakahara M; Zushi S; Kurokawa M; Isotani K; Takamura M; Fujita N; Murakami T
Hepatol Res; 2013 Sep; 43(9):950-8. PubMed ID: 23356912
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report.
Ye J; Huang G; Zhang X; Xu M; Zhou X; Lin M; Xie X; Xie X
Int J Hyperthermia; 2019; 36(1):55-64. PubMed ID: 30444428
[TBL] [Abstract][Full Text] [Related]
18. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma.
Zhong-Zhen S; Kai L; Rong-Qin Z; Er-Jiao X; Ting Z; Ao-Hua Z; Shu-Fang Y; Xu-Qi H
Ultraschall Med; 2012 Dec; 33(7):E250-E255. PubMed ID: 23238803
[TBL] [Abstract][Full Text] [Related]
20. Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration.
Minami Y; Minami T; Ueshima K; Yagyu Y; Tsurusaki M; Okada T; Hori M; Kudo M; Murakami T
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
